Login   Contact Us      
Helping Companies Achieve their Business Goals

Improve Your Reimbursement Results

Serum versus Plasma

Take Control of Your Medicare A/R

Staff Feedback Pays Dividends

Boost Cash Flow by Tracking DSO

Pharmacy Quality Standards

Billing Specialists Get The Job Done

Should you Part D

The Right Team Makes A Great Company

The Importance of Proper Aseptic Technique

The Answers Are in Your Data

Synercid

Inside the 835 - Part 1 - CR Codes

Treating an Unhealthy Accounts Receivable

Are You Compounding or Manufacturing?

Prepare For Bad Debt Reserves

Maximizing Your Value in Mergers and Acquisitions

Is Outsourcing Right For You?

Team Talent is Essential

What's the Value of Your Business

Inside the 835: Part 2--Medicare Codes

Pharmacists Recognized As A Provider:

Part D Success Story: $24K Denied, Then Reversed

Maximize Revenue On Rental Equipment

Leverage Points: Mission and Vision

The Value of Therapeutic Drug Monitoring

Listserv Lessons: Post-dose Vancomycin peak draws

Take Control of Your Patient Receivables

Acquisition Strategy – Securing Management

Pedigree Provisions: A New Responsibility

Cash is still King

Listserv Lessons: Patient Financial Responsibility

HEMOLYSIS - CAUSE AND EFFECT

Who's tracking YOUR sales?

Five Approaches to Training a Sales Person

CASH FLOW: Shows Your Company’s True Health

NPI Deadline is May 23 - Are you ready?

Listserv Lessons: Billing Per Diems on Non-Infused

Microalbumin

Credit Balances, an overlooked problem

Managing Open Invoices

Listserv Lessons: Insurance Company defining AWP

Revenue Recognition: Are You Collecting 95%?

BitLeap's online, offsite data backup system

Is NHIC getting The Job Done?

Drug of the Month - Infliximab

Sed.Rate and C-Reative Protein Assay

A Systemic Approach to Purchasing Negotiations

A Systemic Approach to Purchasing Negotiations 2

Practical Approach to Physician Credentialing

Is Noridian Getting The Job Done?

The Pharmacist’s Awareness of “Drug Induced Diseas

Listserv Lessons: Medicare Billing Split between M

Glycosylated Hemoglobin

Drug of the Month – Daptomycin (Cubicin®)

Using Denial Tracking to Improve Cash Flow and Sta

Dealing with Denial Code 204 (Replacment for PR 96

The Medicare Program: A Brief Overview

ListServ Lessons: Power PICC Flushing Protocols

Can a blood test predict a heart attack?

Software Implementations - do it perfect the first

Drug of the Month – Lynezolid (Zyvox®)

Add a second monitor to your laptop / desktop

Software implementations – it’s a great time to be

Extreme Drug-Resistant Tuberculosis

Listserv Lessons: Home Infusion Pharmacy vs Specia

Patient Satisfaction Scores

Managing your payer pricing files

Leadership: An Analysis

Listserv Lessons: Enteral Practice Standards

MRSA on the Rise

Using Clinicians to Improve Reimbursement

Software Implementations: Multi-site conversions

System Management: Managing Serialized Inventory

So, you have a payer contract…or do you?

Questions and Answers about Lyme Disease

Listserv Lessons: Timely Filing and Patient Debt O

System Implementation: 5 Phases of Information Sy

Managing your Windows Desktop

Insurance Companies Play to Win ... you should too

Blood Culture Contamination

KVO’s on Intermittent Pump Infusions

So, the nice lady at Medicare told you that it wou

Listserv Lessons: Huber Needle Changes

ListServ Lessons: Compounding Question

How many billers necessary to change a light bulb?

Listserv Lessons: Monitoring Shipping

Use of Routine ABNs

Investigating Reimbursement Issues

Repackaging your managed care strategy

Managing your Shared Contract Files

Stale A/R on Legacy Systems – Is It Really Worth I

ListServ Lessons - Infusion of Specialty Meds

Know Who Your Patients Are and Where They Are Comi

Know who your patients are and where they are comi

Patient Pay Accounts - If you can't measure it, yo

Those Pesky Rascals

The Care and Feeding of Your Item Master File

Billing Staff Measurement and Feedback

This Call May be Monitored for Quality Assurance

The Price is Right…Or Maybe Not

Using Time & Motion Studies to Improve Pharmacy Pr

Extreme Drug-Resistant Tuberculosis


Wednesday, June 06, 2007

XDR TB
(Extreme Drug-Resistant Tuberculosis)

The World Health Organization (WHO) recently issued a warning that deadly new

strains of tuberculosis appear to be spreading around the globe. 1 An analysis by the United Nations organization found that new strains, known as extreme drug-resistant tuberculosis (XDR TB) have been found in every continent. 1 The worldwide emergence of XDR TB was first reported in November 2005. 2 The WHO convened an Emergency Global Task Force on XDR TB in 2006, which revised XDR’s definition to specify resistance to at least isoniazid and rifampin among first-line anti-TB drugs, resistance to any fluoroquinolone, and resistance to at least one second-line injectable drug (amikacin, capreomycin, or kanamycin). 3

The biggest areas of XDR TB strains are in Asia and the former Soviet Union. 1 About two percent of all tuberculosis cases are XDR. 1 The drug-resistant strains, which are virtually untreatable, have killed people in the United States, Eastern Europe, and Africa. HIV sufferers are particularly vulnerable because of their weakened immune systems. In people with a compromised immune system, such as HIV-positive people, XDR TB is fatal in about 25 days. 4

Extreme drug resistance is caused by poor TB control, through taking the wrong types of drugs for the incorrect duration. XDR TB spreads like regular TB, by droplets. Anyone who coughs, sneezes, sings or shouts into the air produces droplets that float in the air and can be inhaled by anyone in the area. The cost for a single round of drugs to treat XDR TB can be $10,000. 1 To prevent spread of XDR TB, renewed vigilance is needed through drug-susceptibility testing, case reporting, specialized care, infection control, and expanded capacity for outbreak detection and response. To ensure proper action is taken worldwide to limit the spread of XDR TB the World Health Organization convened a Global XDR TB Task Force devoted to this public health threat. 3

1 “A Deadly Combination: TB and AIDS by Karla Adam; Newsweek Sept 2006 http://www.msnbc.msn.com
2 Shah NS, Wright A, Drobniewski F, et al .Extreme drug resistance inTB9XDR-TB) Int J Tuberc Lung Dis 2005;9(suppl 1);S77
3 CDC. Revised definition of extensively drug-resistant tuberculosis MMWR 2006; 55:1176
4 “ XDRTB” by Peter MAcinnis, 2006 http://www . Greypath.com


Download Article

Home Health Laboratory of America


THE ONLY LAB DESIGNED SPECIFICALLY FOR THE HOME HEALTHCARE INDUSTRY

Home Healthcare Laboratory of America (HHLA) is the leading provider of customized clinical lab services to the home healthcare industry. After years of research, we have developed a system that allows providers to draw blood and ship it directly to HHLA without centrifuging (spinning) the blood. Our proprietary Lab-in-a-Box® kit contains all the necessary blood collection supplies and a pre-addressed diagnostic pouch for overnight shipping. We are able to test whole blood specimens sent from anywhere in the continental U.S. at our state-of-the-art clinical laboratory in Franklin, Tennessee (a suburb of Nashville).

View all articles by Home Health Laboratory of America

 
 


Copyright © 2010 Rock-Pond Solutions. All Rights Reserved.